- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02655861
A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
July 6, 2020 updated by: Yale University
Prospective Evaluation of Infants and Children With Congenital Ichthyosis
This project will follow babies with ichthyosis over time in order to better understand the natural course of ichthyosis in infants and children and to examine how specific genetic mutations affect clinical characteristics.
Study Overview
Detailed Description
The investigators hypothesize that early complications and comorbidities in infants with congenital ichthyosis are genotype-dependent, such that clinical standards of care can be tailored to the genetic diagnoses.
Definition of clinical groups based upon phenotype may also provide useful predictors of outcome.
Information gained from this study will provide the basis for the development of rational standards of care for the future management of children with congenital ichthyosis.
Study Type
Observational
Enrollment (Actual)
21
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06519
- Yale School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Newborns who present at or within 2 months of birth with a clinical diagnosis of ichthyosis, except for infants with a family history of ichthyosis vulgaris and infants with X-linked ichthyosis.
Description
Inclusion Criteria:
- One parent must be able to understand and sign an informed consent document.
- Newborns who present at or within 2 months of birth with a clinical diagnosis of ichthyosis.
- Families must consent to providing DNA for genetic analysis
- Families must agree to the intake evaluation followed by 10 follow-up evaluations, which will occur at ages 1, 2, 3, 6, 9, 12, 18, 24, and 36 months.
Exclusion Criteria:
- Subjects with non-English speaking parents
- Patients with a family history of ichthyosis vulgaris
- Patients with X-linked ichthyosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Ichthyosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: 36 Months
|
To assess growth, birth weight and all weights (in pounds) obtained during hospitalization and clinic visits will be recorded.
The primary outcome of the study will be to determine incidence, timing and severity of "growth failure" in neonates with ichthyosis in relation to genotype at the 3 year pediatric visit.
Weight of the child will primarily be used to make this determination.
|
36 Months
|
Length (Height)
Time Frame: 36 Months
|
To assess growth, birth length and all subsequent measures (in inches) obtained during hospitalization and clinic visits will be recorded.
The primary outcome of the study will be to determine incidence, timing and severity of "growth failure" in neonates with ichthyosis in relation to genotype at the 3 year pediatric visit.
Length of the child will primarily be used to make this determination.
|
36 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months
|
To assess growth, birth weight and all weights (in pounds) obtained during hospitalization and clinic visits will be recorded.
Weight of the child will be used to characterize growth over the course of the 3 year follow up time.
|
Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months
|
Length (Height)
Time Frame: Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months
|
To assess growth, birth length and all subsequent measures (in inches) obtained during hospitalization and clinic visits will be recorded.
Length of the child will be used to characterize growth over the course of the 3 year follow up time.
|
Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months
|
Electrolyte Disturbance
Time Frame: Birth (baseline), 1 month, 2 months, 3 months, 12 months, 24 months, 36 months
|
Measurements of electrolytes, including calcium, phosphate, magnesium, BUN and creatinine values will be used to evaluate the incidence, timing, and severity of electrolyte disturbances and the management of these disturbances in the neonatal period in relation to phenotypic group and to genotype.
This outcome will be captured as a 'yes/no' for any or all of the above.
|
Birth (baseline), 1 month, 2 months, 3 months, 12 months, 24 months, 36 months
|
Systemic Infections
Time Frame: Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
The incidence, severity timing, and causative organisms of systemic infections during neonatal hospital stays will be reviewed in relation to management, including skin care practices and nursing procedures (e.g., open bed vs. humidified isolette).
|
Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
Complications of Congenital Ichthyosis
Time Frame: Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
Clinical severity will be rated using a standardized instrument.
The evolution of skin phenotype will be documented via serial standardized photography.
Transepidermal Water Loss (TEWL) will be measured in some sites.
|
Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
Developmental Delays
Time Frame: Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
To determine the incidence and severity of development delays in relation to genotype, a development history will be obtained at each follow-up evaluation, including information regarding relevant interventions such as physical or occupational therapy.
Physical examination at each visit will assess range of motion of digital and major limb joints.
This outcome will be captured as a 'yes/no' for any or all of the above.
|
Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ear and Eye Conditions
Time Frame: Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
To determine the incidence and severity of ear and eye problems in early childhood in relation to genotype, caregivers will be queried regarding buildup of ear debris and palpebral closure during sleep.
Physical exams will assess ear canal patency, lid closure, and signs of conjunctival irritation.
If participants are evaluated and/or treated by ophthalmology and otolaryngology, these records will be obtained.
This outcome will be captured as a 'yes/no' for any or all of the above.
|
Birth (baseline), 1 month, 2 months, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, 30 months, 36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Brittany Criaglow, MD, Yale University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Actual)
June 5, 2019
Study Completion (Actual)
June 5, 2019
Study Registration Dates
First Submitted
November 16, 2015
First Submitted That Met QC Criteria
January 12, 2016
First Posted (Estimate)
January 14, 2016
Study Record Updates
Last Update Posted (Actual)
July 7, 2020
Last Update Submitted That Met QC Criteria
July 6, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1504015620
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ichthyosis
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAutosomal Recessive Congenital Ichthyosis | Epidermolytic IchthyosisFrance
-
Centre Hospitalier Universitaire de NiceUnknownLamellar IchthyosisFrance
-
Krystal Biotech, Inc.Not yet recruitingAutosomal Recessive IchthyosisUnited States
-
Krystal Biotech, Inc.Active, not recruitingTGM-1 Related Autosomal Recessive Congenital IchthyosisUnited States
-
Northwestern UniversityIcahn School of Medicine at Mount SinaiCompletedNetherton Syndrome | Ichthyosis | Lamellar Ichthyosis | Autosomal Recessive Congenital Ichthyosis | Congenital Ichthyosiform Erythroderma | Epidermolytic IchthyosisUnited States
-
Maastricht University Medical CenterRecruiting
-
Crown Laboratories, Inc.CompletedIchthyosis VulgarisUnited States
-
Patagonia Pharmaceuticals, LLCCompletedCongenital IchthyosisUnited States
-
National Medical Research Center for Children's...RecruitingCongenital IchthyosisRussian Federation
-
University Hospital, ToulouseNot yet recruiting
Clinical Trials on Observation
-
University of MichiganKuwait Foundation for the Advancement of SciencesCompletedGingival RecessionUnited States
-
Centre Hospitalier Régional d'OrléansCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedBrachial Plexus Palsy | Obstetric; InjuryTurkey
-
Abant Izzet Baysal UniversityRecruitingMultiple SclerosisTurkey
-
Universidad Autonoma de MadridCompleted
-
Universidad Autonoma de MadridUnknown
-
University of BergenEuropean Society of Intensive Care MedicineCompletedCritical Illness | Old Age; Debility | SurvivalNorway
-
Istanbul Medeniyet UniversityIstinye University; Ufuk UniversityRecruiting
-
IRCCS San Camillo, Venezia, ItalyUniversità Politecnica delle Marche; University of GenovaUnknown
-
Dokuz Eylul UniversityIzmir Katip Celebi UniversityCompleted